VEGF Antikörper (AA 27-233)
(2 Referenzen)-
- Target Alle VEGF Antikörper anzeigen
- VEGF (Vascular Endothelial Growth Factor (VEGF))
-
Bindungsspezifität
- AA 27-233
-
Reaktivität
- Human, Hund
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser VEGF Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC)
- Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
- Immunogen
- Human recombinant protein fragment corresponding to amino acids 27-233 of human VEGFA (NP_003367) produced in E.coli.
- Klon
- 4G3
- Isotyp
- IgG2b
- Top Product
- Discover our top product VEGF Primärantikörper
-
anti-Vascular Endothelial Growth Factor (VEGF) (AA 27-120) antibody
VEGF Reaktivität: Human, Maus, Ratte, Schwein, Ziege WB, ELISA, IHC (p), IHC (fro), IF (p), FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) antibodyVEGF Reaktivität: Human, Maus, Ratte, Hund, Schwein, Rind (Kuh), Huhn WB, IHC (p), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) antibodyVEGF Reaktivität: Human, Maus, Ratte WB, IHC Wirt: Maus Monoclonal unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) (C-Term) antibodyVEGF Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB11705 unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) antibodyVEGF Reaktivität: Human, Ratte WB, ELISA, IHC, IP, FACS, BR Wirt: Maus Monoclonal A-4-6-1 unconjugated Recombinant Antibody
anti-Vascular Endothelial Growth Factor (VEGF) (AA 27-233) antibodyVEGF Reaktivität: Human WB, IHC, IF Wirt: Maus Monoclonal 4E3 unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) (full length) antibodyVEGF Reaktivität: Human, Maus, Schwein WB, IF Wirt: Huhn Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) antibodyVEGF Reaktivität: Human, Maus, Primate WB, ELISA, IHC Wirt: Maus Monoclonal VG76e unconjugated Recombinant Antibody
anti-Vascular Endothelial Growth Factor (VEGF) antibodyVEGF Reaktivität: Human, Maus, Ratte IF Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB 1:2500~5000, IHC: 1:50-1:150,
- Kommentare
-
The concentration of the product may vary between diferrent lots.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5-1.0 mg/mL
- Buffer
- PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
: "ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling." in: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Vol. 44, Issue 4, pp. 1370-1380, (2018) (PubMed).
: "The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer." in: Journal of cellular and molecular medicine, Vol. 22, Issue 2, pp. 1257-1271, (2018) (PubMed).
-
: "ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling." in: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Vol. 44, Issue 4, pp. 1370-1380, (2018) (PubMed).
-
- Target
- VEGF (Vascular Endothelial Growth Factor (VEGF))
- Andere Bezeichnung
- VEGF (VEGF Produkte)
- Molekulargewicht
- 23.8 kDa
- Gen-ID
- 7422
- NCBI Accession
- NM_001025366
- HGNC
- 7422
-
